6-fluoro-5-[(2R)-2-(5-fluoro-2-methoxy-3-pyridinyl)pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)pyrazolo[1,5-a]pyrimidine
C19H17F2N7O — CID 156770098
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-fluoro-5-[(2R)-2-(5-fluoro-2-methoxy-3-pyridinyl)pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)pyrazolo[1,5-a]pyrimidine
6-fluoro-5-[(2R)-2-(5-fluoro-2-methoxy-3-pyridinyl)pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)pyrazolo[1,5-a]pyrimidine (PubChem CID 156770098) has the molecular formula C19H17F2N7O and a molecular weight of 397.39 g/mol. Its IUPAC name is 6-fluoro-5-[(2R)-2-(5-fluoro-2-methoxy-3-pyridinyl)pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)pyrazolo[1,5-a]pyrimidine.
Molecular Properties
| Compound Name | 6-fluoro-5-[(2R)-2-(5-fluoro-2-methoxy-3-pyridinyl)pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)pyrazolo[1,5-a]pyrimidine |
|---|---|
| PubChem CID | 156770098 |
| Molecular Formula | C19H17F2N7O |
| Molecular Weight | 397.39 g/mol |
| Exact Mass | 397.15 |
| IUPAC Name | 6-fluoro-5-[(2R)-2-(5-fluoro-2-methoxy-3-pyridinyl)pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)pyrazolo[1,5-a]pyrimidine |
| SMILES | COc1ncc(F)cc1[C@H]1CCCN1c1nc2c(-c3cnc[nH]3)cnn2cc1F |
| InChI | InChI=1S/C19H17F2N7O/c1-29-19-12(5-11(20)6-23-19)16-3-2-4-27(16)18-14(21)9-28-17(26-18)13(7-25-28)15-8-22-10-24-15/h5-10,16H,2-4H2,1H3,(H,22,24)/t16-/m1/s1 |
| InChIKey | RLGIMFKKAMMZRP-MRXNPFEDSA-N |
| XLogP | 3.14 |
| TPSA | 84.23 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 397.39 |
| LogP ≤ 5 | 3.14 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156770098 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.